Lamotrigine 25mg Tablets

Manufacturer CADISTA Active Ingredient Lamotrigine Tablets(la MOE tri jeen) Pronunciation la MOE tri jeen
WARNING: Severe skin reactions may happen with this drug. These include Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and other serious reactions. Sometimes, body organs may also be affected. These reactions can be deadly. Get medical help right away if you have signs like red, swollen, blistered, or peeling skin; red or irritated eyes; sores in your mouth, throat, nose, eyes, genitals, or any areas of skin; fever; chills; body aches; shortness of breath; or swollen glands. The chance of a skin reaction is raised in children between 2 and 17 years old. It may also be raised if you take valproic acid or divalproex sodium with this drug, if you start taking this drug at too high of a dose, or if your dose is raised too fast. Skin reactions have also happened without any of these. Talk with your doctor.Most cases of skin reactions have happened within 2 to 8 weeks of starting this drug, but some show up after longer treatment like 6 months. Talk with the doctor. @ COMMON USES: It is used to help control certain kinds of seizures.It is used to treat bipolar disorder.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Anticonvulsant; Mood Stabilizer
đŸ§Ŧ
Pharmacologic Class
Phenyltriazine Antiepileptic
🤰
Pregnancy Category
Category C
✅
FDA Approved
Dec 1994
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Lamotrigine is a medication used to treat certain types of seizures (epilepsy) and to help stabilize mood in people with bipolar disorder. It works by calming overactive nerve signals in the brain. It's very important to start this medication at a very low dose and increase it slowly over several weeks to months to reduce the risk of a serious skin rash.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided to you and follow the instructions closely. You can take this medication with or without food. Continue taking your medication as directed by your doctor or healthcare provider, even if you start feeling well.

It's essential to swallow the medication whole, without chewing, breaking, or crushing it. If you have difficulty swallowing, discuss this with your doctor. Do not change your dose or stop taking this medication without consulting your doctor, as this could lead to seizures. If you need to stop taking this medication, your doctor will instruct you on how to gradually reduce the dose to minimize the risk of side effects.

If you stop taking this medication and need to restart it, your doctor may prescribe a lower dose and gradually increase it. Be sure to discuss this with your doctor.

Storing and Disposing of Your Medication

Store your medication at room temperature, protected from light, and in a dry place. Avoid storing it in a bathroom. Keep all medications in a safe location, out of the reach of children and pets. Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so. If you're unsure about the best way to dispose of your medication, consult your pharmacist. You may also want to check if there are drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or take extra doses.
💡

Lifestyle & Tips

  • Take exactly as prescribed, do not stop abruptly.
  • Do not change your dose without consulting your doctor.
  • Report any rash immediately to your doctor.
  • Avoid alcohol or other CNS depressants, as they may increase dizziness or drowsiness.
  • If you are taking oral contraceptives, discuss with your doctor as your lamotrigine dose may need adjustment.
  • Carry a medical alert card or wear medical identification stating you take lamotrigine.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Highly variable, requires slow titration based on indication and concomitant medications.
Dose Range: 25 - 700 mg

Condition-Specific Dosing:

Epilepsy (monotherapy): Initial: 25 mg once daily for 2 weeks, then 50 mg once daily for 2 weeks. Titrate by 50 mg/day every 1-2 weeks. Maintenance: 225-375 mg/day in 2 divided doses.
Epilepsy (with valproate): Initial: 25 mg every other day for 2 weeks, then 25 mg once daily for 2 weeks. Titrate by 25-50 mg/day every 1-2 weeks. Maintenance: 100-200 mg/day in 1-2 divided doses.
Epilepsy (with enzyme-inducing AEDs, without valproate): Initial: 50 mg once daily for 2 weeks, then 100 mg/day in 2 divided doses for 2 weeks. Titrate by 100 mg/day every 1-2 weeks. Maintenance: 300-500 mg/day in 2 divided doses.
Bipolar I Disorder (monotherapy or with non-inducing AEDs): Initial: 25 mg once daily for 2 weeks, then 50 mg once daily for 2 weeks, then 100 mg once daily for 1 week. Target: 200 mg once daily. Max: 400 mg/day.
Bipolar I Disorder (with valproate): Initial: 25 mg every other day for 2 weeks, then 25 mg once daily for 2 weeks, then 50 mg once daily for 1 week. Target: 100 mg once daily. Max: 200 mg/day.
Bipolar I Disorder (with enzyme-inducing AEDs, without valproate): Initial: 50 mg once daily for 2 weeks, then 100 mg/day in 2 divided doses for 2 weeks, then 200 mg/day in 2 divided doses for 1 week. Target: 300 mg/day. Max: 400 mg/day.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established (safety and efficacy not established in children <2 years for epilepsy, <18 years for bipolar disorder).
Child: Epilepsy (2-12 years): Dosing is weight-based and highly dependent on concomitant medications (e.g., with valproate: 0.15 mg/kg/day initially; with enzyme inducers: 0.6 mg/kg/day initially). Requires careful titration.
Adolescent: Epilepsy (>12 years): Same as adult dosing. Bipolar I Disorder (>18 years): Same as adult dosing.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment needed.
Moderate: Consider dose reduction in patients with significant renal impairment. Monitor clinical response.
Severe: Consider 25% dose reduction. Monitor clinical response and adverse effects. (CrCl < 30 mL/min)
Dialysis: Supplemental doses after dialysis are generally not needed as only a small fraction is removed. Monitor clinical response.

Hepatic Impairment:

Mild: No specific adjustment needed.
Moderate: Initial dose reduction by 25% and subsequent dose escalation by 50% (Child-Pugh Class B).
Severe: Initial dose reduction by 50% and subsequent dose escalation by 75% (Child-Pugh Class C). Monitor closely for adverse effects.
Confidence: Medium

Pharmacology

đŸ”Ŧ

Mechanism of Action

Lamotrigine is a phenyltriazine derivative that stabilizes neuronal membranes and inhibits the release of excitatory neurotransmitters (primarily glutamate and aspartate). It achieves this by blocking voltage-sensitive sodium channels, thereby inhibiting sustained repetitive firing of neurons. It also weakly inhibits voltage-gated calcium channels.
📊

Pharmacokinetics

Absorption:

Bioavailability: 98% (oral)
Tmax: 1.4 to 4.8 hours (oral)
FoodEffect: Food does not significantly affect the rate or extent of absorption.

Distribution:

Vd: 0.97 to 1.36 L/kg
ProteinBinding: Approximately 55%
CnssPenetration: Yes (readily crosses blood-brain barrier)

Elimination:

HalfLife: Approximately 25-33 hours (monotherapy); significantly affected by concomitant medications (e.g., ~15 hours with enzyme inducers, ~59 hours with valproate).
Clearance: Approximately 0.3-0.4 mL/min/kg
ExcretionRoute: Renal (approximately 94% as metabolites, 6% as unchanged drug)
Unchanged: Approximately 6-10%
âąī¸

Pharmacodynamics

OnsetOfAction: Weeks (due to slow titration required to minimize rash risk)
PeakEffect: Weeks to months (after reaching stable maintenance dose)
DurationOfAction: 24 hours (given once or twice daily)
Confidence: Medium

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Serious Skin Rashes: Lamotrigine can cause serious rashes requiring hospitalization and discontinuation of treatment. These include Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which can result in death. The incidence of these rashes, which have been reported in association with lamotrigine, is approximately 0.3% to 0.8% in pediatric patients (aged 2 to 16 years) and 0.08% to 0.3% in adults. Risk factors include initial dose, rate of dose escalation, and concomitant use of valproate. Benign rashes also occur, but it is not possible to predict which rashes will prove to be serious or life-threatening. Therefore, lamotrigine should ordinarily be discontinued at the first sign of rash, unless the rash is clearly not drug-related.
âš ī¸

Side Effects

Serious Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness or swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Signs of liver problems, such as:
+ Dark urine
+ Fatigue
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Shortness of breath, sudden weight gain, or swelling in the arms or legs
Severe muscle pain or weakness
Severe joint pain or swelling
Changes in vision
Chest pain or pressure
Abnormal heartbeat (fast, slow, or irregular)
Severe dizziness or fainting
Balance problems
Uncontrolled eye movements
Flu-like symptoms
Painful periods or changes in menstrual cycle, including spotting or bleeding between cycles

Low Blood Cell Counts

This medication can cause low blood cell counts, which may lead to bleeding problems, infections, or anemia. If you experience any of the following symptoms, contact your doctor right away:

Signs of infection, such as fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling extremely tired or weak

Immune System Problem (Hemophagocytic Lymphohistiocytosis)

In rare cases, this medication can cause a life-threatening immune system problem called hemophagocytic lymphohistiocytosis (HLH). If you experience any of the following symptoms, contact your doctor immediately:

Fever
Swollen glands
Rash
Seizures
Confusion or decreased alertness
Balance problems
Difficulty walking (new or worsening)

Other Side Effects

Most people do not experience serious side effects, and many have only minor or no side effects at all. However, if you notice any of the following side effects, contact your doctor or seek medical attention if they bother you or do not go away:

Dizziness, drowsiness, fatigue, or weakness
Constipation, diarrhea, stomach pain, upset stomach, vomiting, or decreased appetite
Shakiness
Sleep disturbances
Nose or throat irritation
Weight loss
Dry mouth
Back pain

Reporting Side Effects

If you have questions about side effects or want to report any side effects, contact your doctor or call the FDA at 1-800-332-1088. You can also report side effects online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Any new or worsening skin rash (especially blistering, peeling, or involving mouth/eyes/genitals)
  • Fever, swollen glands, or flu-like symptoms
  • Swelling of the face, eyes, lips, or tongue
  • Sore throat or mouth sores
  • Unusual bruising or bleeding
  • Yellowing of the skin or eyes (jaundice)
  • Dark urine
  • Severe fatigue or weakness
  • New or worsening depression, suicidal thoughts, or unusual changes in mood or behavior
  • Severe dizziness, loss of coordination, or vision changes
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
If you are currently taking dofetilide, as this may interact with the medication.

To ensure safe treatment, it is crucial to provide your doctor and pharmacist with a comprehensive list of:

All prescription and over-the-counter (OTC) medications you are taking
Any natural products or vitamins you are using
* Your existing health problems

This information will help your doctor determine whether it is safe for you to take this medication in conjunction with your other medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor to confirm that it is safe to do so.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

When taking this medication, it is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are using this drug.

Caution with Daily Activities
Avoid driving and engaging in activities that require alertness until you understand how this medication affects you. It may take several weeks to experience the full effects of the drug.

Monitoring and Lab Tests
Regular blood work is necessary, as directed by your doctor. Be sure to discuss any concerns with your doctor. Additionally, this medication may interfere with certain lab tests, so inform all your healthcare providers and lab personnel that you are taking this drug.

Interactions with Other Substances
Before consuming alcohol, marijuana, or other forms of cannabis, or using prescription or over-the-counter (OTC) medications that may cause drowsiness, consult with your doctor.

Mental Health and Suicidal Thoughts
Like other seizure medications, this drug may rarely increase the risk of suicidal thoughts or actions, particularly in individuals with a history of suicidal thoughts or actions. Immediately contact your doctor if you experience new or worsening symptoms such as depression, anxiety, restlessness, irritability, panic attacks, or mood changes. If you have suicidal thoughts or actions, seek medical attention right away.

Risk of Aseptic Meningitis
This medication may increase the risk of a severe brain problem called aseptic meningitis. Seek medical attention immediately if you experience symptoms such as headache, fever, chills, severe nausea or vomiting, stiff neck, rash, sensitivity to light, drowsiness, or confusion.

Medication Verification
Always verify that you have the correct medication, as some drugs may have similar names or appearances. If you notice any changes in the medication's shape, color, size, or labeling, consult with your pharmacist.

Heart Problems
If you have an abnormal heartbeat, heart failure, or other heart problems, discuss the risks with your doctor. Abnormal heartbeats can increase the risk of sudden death in individuals with certain heart conditions.

Pediatric Use
When using this medication in children, exercise caution, as the risk of certain side effects may be higher in this population.

Birth Control and Hormone Interactions
Birth control pills and other hormone-based birth control methods may affect the levels of this medication in your body. Consult with your doctor before starting or stopping any hormone-based birth control. The risk of side effects may be increased during the week when birth control pills are not active. Additionally, birth control pills and other hormone-based methods may be less effective in preventing pregnancy when taking this medication. Use an alternative form of birth control, such as a condom, to prevent pregnancy.

Pregnancy and Breastfeeding
If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the benefits and risks of this medication with your doctor.

Seizure Management
If your seizures change or worsen after starting this medication, consult with your doctor to adjust your treatment plan.
🆘

Overdose Information

Overdose Symptoms:

  • Ataxia (loss of coordination)
  • Nystagmus (involuntary eye movements)
  • Increased seizures
  • Decreased consciousness
  • Coma
  • Cardiac conduction abnormalities (e.g., QRS prolongation)

What to Do:

Seek immediate medical attention. Call 911 or Poison Control (1-800-222-1222). Treatment is supportive; there is no specific antidote. Activated charcoal may be considered if ingested recently.

Drug Interactions

🔴

Major Interactions

  • Valproate (valproic acid, divalproex sodium): Significantly decreases lamotrigine clearance, increasing lamotrigine levels and risk of serious rash. Requires significant lamotrigine dose reduction.
  • Carbamazepine, Phenytoin, Phenobarbital, Primidone: Significantly increase lamotrigine clearance, decreasing lamotrigine levels. Requires significant lamotrigine dose increase.
  • Oral Contraceptives (containing estrogen): May decrease lamotrigine levels by up to 50%. Requires lamotrigine dose adjustment. Breakthrough seizures or loss of mood stability may occur.
  • Rifampin: Significantly increases lamotrigine clearance, decreasing lamotrigine levels.
  • Lopinavir/ritonavir, Atazanavir/ritonavir: May decrease lamotrigine levels.
🟡

Moderate Interactions

  • Risperidone: May increase lamotrigine levels (mechanism unclear).
  • Paroxetine, Sertraline: May increase lamotrigine levels (weak inhibition of glucuronidation).
  • Topiramate: May increase lamotrigine levels (mechanism unclear).
  • Ethanol: May increase CNS depression.
đŸŸĸ

Minor Interactions

  • Acetaminophen: High doses may slightly decrease lamotrigine levels (glucuronidation competition).

Monitoring

đŸ”Ŧ

Baseline Monitoring

Complete Blood Count (CBC)

Rationale: To establish baseline and monitor for potential hematologic abnormalities (rare).

Timing: Before initiation

Liver Function Tests (LFTs)

Rationale: To establish baseline and monitor for potential hepatic dysfunction (rare).

Timing: Before initiation

Renal Function Tests (Creatinine, BUN)

Rationale: To establish baseline, especially if renal impairment is suspected or present.

Timing: Before initiation

📊

Routine Monitoring

Clinical response (seizure frequency/severity, mood stability)

Frequency: Regularly during titration and maintenance

Target: Individualized

Action Threshold: Lack of efficacy or worsening symptoms

Adverse effects (especially rash, CNS effects)

Frequency: Daily during titration, then regularly

Target: Absence of severe adverse effects

Action Threshold: Appearance of rash, severe dizziness, ataxia, vision changes, etc.

Lamotrigine plasma concentrations (Therapeutic Drug Monitoring - TDM)

Frequency: Not routinely recommended for all patients, but useful in specific situations (e.g., suspected non-adherence, drug interactions, renal/hepatic impairment, pregnancy, treatment failure, toxicity).

Target: Epilepsy: 3-14 mcg/mL (free and total levels vary); Bipolar: 2-10 mcg/mL (guideline, not definitive)

Action Threshold: Levels outside therapeutic range, or symptoms of toxicity/inefficacy despite adequate dosing.

đŸ‘ī¸

Symptom Monitoring

  • Skin rash (any type, especially widespread, blistering, or involving mucous membranes)
  • Fever
  • Swollen lymph nodes
  • Swelling of face, eyes, lips, tongue
  • Sore throat
  • Mouth sores
  • Unusual bruising or bleeding
  • Yellowing of skin or eyes (jaundice)
  • Dark urine
  • Severe fatigue
  • Dizziness
  • Ataxia (lack of coordination)
  • Blurred or double vision
  • Headache
  • Nausea/vomiting
  • Insomnia
  • Tremor
  • Changes in mood or behavior (e.g., depression, suicidal thoughts, aggression, agitation)

Special Patient Groups

🤰

Pregnancy

Use during pregnancy should be carefully considered. While classified as Category C, data from pregnancy registries suggest that the risk of major congenital malformations with lamotrigine monotherapy is relatively low (around 1-3%), similar to the general population. However, higher risks may be associated with polytherapy, especially with valproate. Folic acid supplementation is generally recommended for women of childbearing potential taking AEDs.

Trimester-Specific Risks:

First Trimester: Potential for increased risk of oral clefts (though data are conflicting and overall risk appears low).
Second Trimester: Generally considered safer than first trimester for initiation/continuation.
Third Trimester: Lamotrigine levels may decrease significantly during pregnancy due to increased clearance, potentially leading to loss of seizure control. Dose adjustments may be necessary. Levels typically return to pre-pregnancy levels postpartum, requiring dose reduction to avoid toxicity.
🤱

Lactation

Lamotrigine is excreted into breast milk. While generally considered compatible with breastfeeding by some experts (L3), infant monitoring for adverse effects (e.g., rash, drowsiness, poor feeding, apnea) is recommended, especially in neonates or if high doses are used. Infant serum levels can be significant.

Infant Risk: Risk of drowsiness, poor feeding, rash, and apnea in breastfed infants. Monitor infant closely.
đŸ‘ļ

Pediatric Use

Safety and efficacy for bipolar disorder not established in patients under 18 years. For epilepsy, approved for children â‰Ĩ2 years. Dosing is complex and weight-based, requiring careful titration due to higher risk of serious rash in younger children.

👴

Geriatric Use

No specific dose adjustments are generally needed based on age alone, but elderly patients may be more sensitive to adverse effects (e.g., dizziness, ataxia) and may have age-related decreases in renal or hepatic function, requiring dose adjustments based on those impairments. Start low and titrate slowly.

Clinical Information

💎

Clinical Pearls

  • The most critical aspect of lamotrigine therapy is slow dose titration to minimize the risk of serious skin rash. Never accelerate the titration schedule.
  • Concomitant valproate significantly increases lamotrigine levels, requiring a much slower and lower lamotrigine titration. Concomitant enzyme-inducing AEDs (e.g., carbamazepine, phenytoin) significantly decrease lamotrigine levels, requiring a faster and higher lamotrigine titration.
  • Patients should be educated to report any rash immediately. While most rashes are benign, it's impossible to distinguish serious from benign rashes early on, so discontinuation is often recommended.
  • Lamotrigine is effective for both focal and generalized seizures, including Lennox-Gastaut syndrome, and is a first-line mood stabilizer for bipolar depression.
  • Therapeutic drug monitoring (TDM) is not routinely required but can be useful in specific situations (e.g., suspected non-adherence, drug interactions, pregnancy, renal/hepatic impairment, treatment failure, toxicity).
🔄

Alternative Therapies

  • For Epilepsy: Levetiracetam, Carbamazepine, Valproate, Phenytoin, Topiramate, Oxcarbazepine, Zonisamide, Gabapentin, Pregabalin.
  • For Bipolar Disorder (Mood Stabilizers): Lithium, Valproate (divalproex), Carbamazepine, Atypical Antipsychotics (e.g., Quetiapine, Olanzapine, Lurasidone, Cariprazine).
💰

Cost & Coverage

Average Cost: $10 - $50 per 30 tablets (25mg generic)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, a patient fact sheet that provides important information. Please read it carefully and review it again whenever you receive a refill. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, pharmacist, or other healthcare provider.

In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. Be prepared to provide details about the overdose, including the medication taken, the amount, and the time it occurred.